US Stock MarketDetailed Quotes

HRTX Heron Therapeutics

Watchlist
  • 1.090
  • -0.030-2.68%
Trading Nov 21 13:15 ET
165.78MMarket Cap-6812P/E (TTM)

Heron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
4.38%32.81M
13.42%36.02M
17.07%34.67M
17.99%127.04M
14.00%34.23M
18.36%31.43M
14.95%31.76M
26.25%29.62M
24.70%107.67M
45.38%30.03M
Operating revenue
4.38%32.81M
13.42%36.02M
17.07%34.67M
17.99%127.04M
14.00%34.23M
18.36%31.43M
14.95%31.76M
26.25%29.62M
24.70%107.67M
45.38%30.03M
Cost of revenue
-48.06%9.46M
-47.82%10.52M
-49.90%8.44M
18.64%65.11M
-21.72%9.89M
23.72%18.21M
24.62%20.16M
48.43%16.85M
19.24%54.87M
15.41%12.63M
Gross profit
76.56%23.35M
119.80%25.51M
105.52%26.23M
17.31%61.94M
39.92%24.35M
11.71%13.23M
1.30%11.6M
5.45%12.76M
30.93%52.8M
79.13%17.4M
Operating expense
-27.11%27.81M
-40.84%31.95M
-32.30%31.02M
-24.14%172.55M
-8.44%34.57M
-28.98%38.16M
-11.40%54.01M
-38.92%45.82M
-11.89%227.46M
-40.31%37.76M
Selling and administrative expenses
-19.14%23.35M
-32.55%27.52M
-28.58%26.42M
-2.75%116.66M
-62.54%10M
2.46%28.87M
27.02%40.8M
12.24%36.99M
-5.80%119.95M
-22.33%26.7M
-Selling and marketing expense
-15.31%10.97M
-35.80%13.61M
-45.91%11.44M
-18.02%67.64M
-30.64%12.33M
-29.50%12.96M
-7.56%21.21M
-9.68%21.15M
-5.35%82.51M
-27.41%17.78M
-General and administrative expense
-22.25%12.37M
-29.03%13.91M
-5.43%14.97M
30.92%49.01M
-126.06%-2.33M
62.40%15.91M
113.40%19.59M
66.10%15.83M
-6.76%37.44M
-9.74%8.92M
Research and development costs
-51.91%4.47M
-66.45%4.43M
-47.85%4.61M
-48.01%55.9M
122.18%24.57M
-63.65%9.29M
-54.19%13.21M
-79.00%8.84M
-17.82%107.51M
-61.71%11.06M
Operating profit
82.12%-4.46M
84.80%-6.45M
85.49%-4.8M
36.67%-110.62M
49.79%-10.22M
40.48%-24.93M
14.33%-42.4M
47.45%-33.06M
19.82%-174.66M
61.98%-20.36M
Net non-operating interest income expense
39.71%-504K
57.71%-836K
Non-operating interest income
----
----
----
105.37%3.36M
----
----
----
----
278.29%1.64M
----
Non-operating interest expense
----
----
----
56.35%3.87M
----
----
----
----
2.66%2.47M
----
Other net income (expense)
-393.67%-390K
-911.05%-2.79M
455.25%1.64M
108.58%560K
0
-203.85%-79K
105.01%344K
130.57%295K
-643.74%-6.53M
52.30%1.32M
Other non- operating income (expenses)
-393.67%-390K
-911.05%-2.79M
455.25%1.64M
108.58%560K
--0
-203.85%-79K
105.01%344K
130.57%295K
-643.74%-6.53M
52.30%1.32M
Income before tax
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
Income tax
Net income
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
Net income continuous Operations
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
Minority interest income
Net income attributable to the parent company
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
Basic earnings per share
82.35%-0.03
82.86%-0.06
92.59%-0.02
52.10%-0.8
70.59%-0.05
55.26%-0.17
36.36%-0.35
57.14%-0.27
25.45%-1.67
68.52%-0.17
Diluted earnings per share
82.35%-0.03
82.86%-0.06
92.59%-0.02
52.10%-0.8
70.59%-0.05
55.26%-0.17
36.36%-0.35
57.14%-0.27
25.45%-1.67
68.52%-0.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 4.38%32.81M13.42%36.02M17.07%34.67M17.99%127.04M14.00%34.23M18.36%31.43M14.95%31.76M26.25%29.62M24.70%107.67M45.38%30.03M
Operating revenue 4.38%32.81M13.42%36.02M17.07%34.67M17.99%127.04M14.00%34.23M18.36%31.43M14.95%31.76M26.25%29.62M24.70%107.67M45.38%30.03M
Cost of revenue -48.06%9.46M-47.82%10.52M-49.90%8.44M18.64%65.11M-21.72%9.89M23.72%18.21M24.62%20.16M48.43%16.85M19.24%54.87M15.41%12.63M
Gross profit 76.56%23.35M119.80%25.51M105.52%26.23M17.31%61.94M39.92%24.35M11.71%13.23M1.30%11.6M5.45%12.76M30.93%52.8M79.13%17.4M
Operating expense -27.11%27.81M-40.84%31.95M-32.30%31.02M-24.14%172.55M-8.44%34.57M-28.98%38.16M-11.40%54.01M-38.92%45.82M-11.89%227.46M-40.31%37.76M
Selling and administrative expenses -19.14%23.35M-32.55%27.52M-28.58%26.42M-2.75%116.66M-62.54%10M2.46%28.87M27.02%40.8M12.24%36.99M-5.80%119.95M-22.33%26.7M
-Selling and marketing expense -15.31%10.97M-35.80%13.61M-45.91%11.44M-18.02%67.64M-30.64%12.33M-29.50%12.96M-7.56%21.21M-9.68%21.15M-5.35%82.51M-27.41%17.78M
-General and administrative expense -22.25%12.37M-29.03%13.91M-5.43%14.97M30.92%49.01M-126.06%-2.33M62.40%15.91M113.40%19.59M66.10%15.83M-6.76%37.44M-9.74%8.92M
Research and development costs -51.91%4.47M-66.45%4.43M-47.85%4.61M-48.01%55.9M122.18%24.57M-63.65%9.29M-54.19%13.21M-79.00%8.84M-17.82%107.51M-61.71%11.06M
Operating profit 82.12%-4.46M84.80%-6.45M85.49%-4.8M36.67%-110.62M49.79%-10.22M40.48%-24.93M14.33%-42.4M47.45%-33.06M19.82%-174.66M61.98%-20.36M
Net non-operating interest income expense 39.71%-504K57.71%-836K
Non-operating interest income ------------105.37%3.36M----------------278.29%1.64M----
Non-operating interest expense ------------56.35%3.87M----------------2.66%2.47M----
Other net income (expense) -393.67%-390K-911.05%-2.79M455.25%1.64M108.58%560K0-203.85%-79K105.01%344K130.57%295K-643.74%-6.53M52.30%1.32M
Other non- operating income (expenses) -393.67%-390K-911.05%-2.79M455.25%1.64M108.58%560K--0-203.85%-79K105.01%344K130.57%295K-643.74%-6.53M52.30%1.32M
Income before tax 80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M
Income tax
Net income 80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M
Net income continuous Operations 80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M
Minority interest income
Net income attributable to the parent company 80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M
Basic earnings per share 82.35%-0.0382.86%-0.0692.59%-0.0252.10%-0.870.59%-0.0555.26%-0.1736.36%-0.3557.14%-0.2725.45%-1.6768.52%-0.17
Diluted earnings per share 82.35%-0.0382.86%-0.0692.59%-0.0252.10%-0.870.59%-0.0555.26%-0.1736.36%-0.3557.14%-0.2725.45%-1.6768.52%-0.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data